OUR DIVISIONS
Climate Change & ESG Division
At CCP’s Climate Change & ESG Division, we partner with ambitious organizations (from scaling ventures to corporates and policy bodies) to design and execute climate strategies, ESG frameworks, and decarbonization roadmaps that are credible, measurable, and future-shaping.
Read more
Biotech, Pharma & Vaccine Development
In an era defined by biological innovation (personalised therapies, novel biologics, vaccines, precision medicines) success demands more than lab breakthroughs. It demands development rigor, regulatory foresight, translational discipline, and strategic commercial insight.
Read more
Sensor and assay development
Modern diagnostics, life sciences, environmental monitoring, industrial process control, all depend on robust sensors and assays. At CCP’s Sensor and Assay Development Division, we partner with innovators to transform prototypes and concepts into reliable, scalable sensing and measurement systems.
Read more
Nanotechnology and Polymers
Our Nanotechnology and Polymers division works across the full innovation cycle, from molecular design to market deployment, helping clients translate complex materials science into tangible commercial advantage. We combine deep technical know-how with strategic foresight, ensuring that every innovation is scalable, compliant and market-ready.
Read more
Venture Acceleration & Scale-Up Strategy
Early-stage companies move fast, but only the well-prepared sustain growth. Our Venture Acceleration & Scale-Up Strategy Division supports founders from first sketch to full market entry. We assemble specialists in proof-of-concept validation, innovation management, product-road-mapping, and cost-of-goods (COGS) optimisation, then add fundraising and IP advisers, regulatory guides, and scale-up engineers as required.
Read more




